Delivering Therapeutic Proteins into Cells Using Biological Nanoparticles
Presented by Aditya Raguram, Fellow, Whitehead Institute
In this webinar, Whitehead Fellow Aditya Raguram will discuss how his lab develops biological nanoparticles that can safely and efficiently deliver therapeutic proteins into cells within the body. And he'll describe how these delivery technologies could enable new therapies for genetic disorders, cancer, and other diseases.
Live webinar. Free and open to all.
Moderator
Jonathan Weissman
Member and Landon T. Clay Professor, Whitehead Institute
Professor of Biology, MIT
Investigator of the Howard Hughes Medical Institute
Aditya Raguram
Raguram earned an A.B. in Chemistry and Physics in 2018 from Harvard College. His undergraduate research spanned molecular, chemical, and computational biology at the Singapore-MIT Alliance for Research and Technology (Singapore), the MRC Laboratory of Molecular Biology (Cambridge, UK), and the Broad Institute of MIT and Harvard. Raguram subsequently earned a Ph.D. in Chemical Biology in 2023 from Harvard University, under the mentorship of Prof. David R. Liu. He joined Whitehead Institute in 2023 as a Whitehead Fellow.
Jonathan Weissman
Weissman earned his bachelor’s degree in physics from Harvard College in 1988, graduating summa cum laude. He next took on a PhD in physics from MIT, where he studied under biochemist Peter S. Kim, and from 1993-1996 he completed a postdoctoral fellowship at Yale in the lab of Arthur Horwich. For the past 24 years he has held faculty positions in the Departments of Cell and Molecular Pharmacology and Biochemistry & Biophysics at the University of California, San Francisco, until joining Whitehead Institute in 2020. He also co-leads the Laboratory for Genomic Research, funded by GlaxoSmithKline, to drive development of CRISPR-based therapeutics.
